ライフサイエンスコーパス: radiofrequency ablation

1 to cryoballoon ablation and 384 assigned to radiofrequency ablation).

2 fine identification of substrate targets for radiofrequency ablation.

3 gard to the risk of late AF recurrence after radiofrequency ablation.

4 ead to a promising alternative to epicardial radiofrequency ablation.

5 tial impedance are poor predictors of CF for radiofrequency ablation.

6 ge is a hazardous complication of epicardial radiofrequency ablation.

7 le VGLA catheter with an efficacy similar to radiofrequency ablation.

8 eart and its implications for treatment with radiofrequency ablation.

9 mplete eradication of Barrett's esophagus by radiofrequency ablation.

10 t of lesion formation for atrial endocardial radiofrequency ablation.

11 ircumvent the limitations of cryoblation and radiofrequency ablation.

12 T (12 out of 25 animals) underwent immediate radiofrequency ablation.

13 n ablation are similar to those reported for radiofrequency ablation.

14 resection, intraoperative brachytherapy, and radiofrequency ablation.

15 emain about incomplete tumor cell kill after radiofrequency ablation.

16 ing the AV node is feasible by transcatheter radiofrequency ablation.

17 s, posterior mitral line was performed using radiofrequency ablation.

18 ear lesions were created using either PFA or radiofrequency ablation.

19 density to increase the therapeutic range of radiofrequency ablation.

20 ctive technique for increasing the effect of radiofrequency ablation.

21 ed to improve success rate of point-by-point radiofrequency ablation.

22 ection accurately shows edema resulting from radiofrequency ablation.

23 lionated plexuses was performed, followed by radiofrequency ablation.

24 familial AVNRT among patients who underwent radiofrequency ablation.

25 chycardia underwent catheter cryoablation or radiofrequency ablation.

26 ients with persistent AF undergoing stepwise radiofrequency ablation.

27 areas of abnormal electrograms as target for radiofrequency ablation.

28 t a median of 462 days (Q1-Q3=319-1026) post radiofrequency ablation.

29 and had failed multiple antiarrhythmics and radiofrequency ablations.

30 cteristics of gadolinium-enhanced imaging of radiofrequency ablations.

31 the decision to ablate: (1) complication of radiofrequency ablation, (2) success of radiofrequency a

32 s esophagus in a 2:1 ratio to receive either radiofrequency ablation (ablation group) or a sham proce

33 :1 ratio to either endoscopic treatment with radiofrequency ablation (ablation) or endoscopic surveil

34 After 23.8 minutes (18.1-28.5) of radiofrequency ablation, abnormal electrograms disappear

35 idence (3 trials; n = 30 to 198) showed that radiofrequency ablation after a failed drug course was m

36 nical practice to perform such procedures as radiofrequency ablation and biopsy; however, the applica

37 Clinical studies to date indicate that radiofrequency ablation and cryoablation are effective t

38 The results following percutaneous radiofrequency ablation and cryoablation in the treatmen

39 the Cox-Maze IV procedure utilizing bipolar radiofrequency ablation and cryoablation, long-term stud

40 ) in detecting abnormal atrial tissue before radiofrequency ablation and in predicting procedural out

41 low for programmable electrical stimulation, radiofrequency ablation and irreversible electroporation

42 the risk:benefit ratios between prophylactic radiofrequency ablation and no treatment in asymptomatic

43 d superior vena cava (SVC) isolation between radiofrequency ablation and PFA waveforms.

44 usually be eliminated by sequential unipolar radiofrequency ablation and sometimes required simultane

45 n of radiofrequency ablation, (2) success of radiofrequency ablation, and (3) sudden death in asympto

46 nd ablative procedures such as cryoablation, radiofrequency ablation, and recently radiosurgery.

47 terial and periarterial tissue damage during radiofrequency ablation, and there is a trend toward les

48 effectiveness of tumor ablation from a given radiofrequency ablation application, including increased

49 Three- and 4-year data for cryoablation and radiofrequency ablation are now becoming available.

50 Photodynamic therapy and radiofrequency ablation are recently developed, emerging

51 Cryoablation and radiofrequency ablation are the two most utilized forms

52 such as transarterial chemoembolization and radiofrequency ablation are used for hepatic metastatic

53 and intestinal metaplasia can be achieved by radiofrequency ablation as demonstrated in a randomized

54 ell as interstitial techniques, particularly radiofrequency ablation as the most commonly applied tec

55 The net cost of patients receiving radiofrequency ablation as the only treatment was relati

56 ed with a high rate of VT termination during radiofrequency ablation as well as noninducibility at st

57 ETHODS AND NYHA II-IV patients undergoing VT radiofrequency ablation at 12 international centers were

58 h structural heart disease presenting for VT radiofrequency ablation at 2 centers were included.

59 lar tachycardia had unsuccessful response to radiofrequency ablation at critical sites (number of app

60 splant recipients, 53% among cases receiving radiofrequency ablation at early stage, 47% among cases

61 ctively gathered data in children undergoing radiofrequency ablation at our institution since the ins

62 ton pump inhibitor therapy elimination after radiofrequency ablation at the gastroesophageal junction

63 Atrioventricular nodal radiofrequency ablation (AVNA) with permanent ventricula

64 ed atrial tachycardias (AT) allows efficient radiofrequency ablation by targeting the critical isthmu

65 Radiofrequency ablation can be evaluated accurately by u

66 Despite greater baseline comorbidities, VT radiofrequency ablation can be safely performed among NY

67 rgeted during VT with the remotely navigated radiofrequency ablation catheter alone.

68 f PVs and requiring touch-up with a standard radiofrequency ablation catheter in 22.7% (45/198) PVs.

69 ed using a specially designed open-irrigated radiofrequency ablation catheter incorporating 4 ultraso

70 afety and effectiveness of a novel irrigated radiofrequency ablation catheter that measures real-time

71 to assess the safety and outcome of a novel radiofrequency ablation catheter that used an extendable

72 A radiofrequency ablation catheter with integrated CF sens

73 tent AF underwent APVI with an irrigated-tip radiofrequency ablation catheter.

74 ic paroxysmal AF with the use of an 8-mm tip radiofrequency ablation catheter.

75 t research findings in contact force-sensing radiofrequency ablation catheters.

76 actory paroxysmal AF to contact force-guided radiofrequency ablation (CF-RF; n=115), 4-minute cryobal

77 gical intervention (by chemoembolisation and radiofrequency ablation), chemotherapy, and somatostatin

78 hout previous antiarrhythmic drug treatment, radiofrequency ablation compared with antiarrhythmic dru

79 Baseline estimates of sudden death and radiofrequency ablation complication rates were obtained

80 ge strategy combining limited resections and radiofrequency ablation could be proposed as an option i

81 We assessed whether endoscopic radiofrequency ablation could eradicate dysplastic Barre

82 Computed tomography-guided radiofrequency ablation (CT-RFA) and laparoscopic RFA (L

83 hythmia recurrence, a second procedure using radiofrequency ablation demonstrated left atrial to pulm

84 Radiofrequency ablation depth can be inadequate to reach

85 lsed-field ablation), expandable lattice-tip radiofrequency ablation/electroporation, and ultra-low t

86 Radiofrequency ablation eliminated AES leading to ECG no

87 Radiofrequency ablation eliminated all arrhythmias origi

88 sus endoscopic mucosal resection followed by radiofrequency ablation (EMR-RFA) for the treatment of B

89 After radiofrequency ablation, flecainide and remap confirmed

90 dial injury, and prothrombotic markers after radiofrequency ablation for AF and its relation to AF re

91 Patients undergoing radiofrequency ablation for AF exhibit an inflammatory r

92 ith 7-day Holter recordings at 6 months post radiofrequency ablation for AF.

93 6-month study period, 145 patients underwent radiofrequency ablation for AP-mediated tachycardia.

94 liver transplantation, hepatic resection, or radiofrequency ablation for HCC were reviewed.

95 Fifteen patients undergoing first-time radiofrequency ablation for nonparoxysmal atrial fibrill

96 Radiofrequency ablation for postinfarct VT is reserved f

97 ged 63.0+/-13.2 years) who underwent a first radiofrequency ablation for sustained monomorphic VT ass

98 peutic vagal denervation through endocardial radiofrequency ablation for these cases.

99 Radiofrequency ablation for ventricular arrhythmias is l

100 There is paucity of data regarding radiofrequency ablation for ventricular tachycardia (VT)

101 Radiofrequency ablation for ventricular tachycardia is a

102 equential or simultaneous irrigated unipolar radiofrequency ablation from the endocardial and epicard

103 Radiofrequency ablation from the first suitable site was

104 in the ultrasound ablation group than in the radiofrequency ablation group of the main renal artery (

105 the antiarrhythmic drug group and 66 in the radiofrequency ablation group were followed up for 24 mo

106 significant difference was found between the radiofrequency ablation groups (-8.3+/-11.7 mm Hg for ad

107 Ventricular tachycardia (VT) radiofrequency ablation has been associated with reduced

108 Radiofrequency ablation has emerged as an excellent opti

109 ive-year outcomes following cryoablation and radiofrequency ablation have recently been published, re

110 form of freezing (cryoablation) and heating (radiofrequency ablation) have been utilized successfully

111 During radiofrequency ablation, high electrode-tissue contact f

112 After a failed response to radiofrequency ablation, impedance was modulated by addi

113 trospective study [n = 1171]) suggested that radiofrequency ablation improved quality of life, promot

114 emature ventricular contractions (PVC) using radiofrequency ablation improves effectiveness of the ca

115 Three randomized trials showed that radiofrequency ablation improves survival when compared

116 in 7 and 7 swine sequentially and irrigated radiofrequency ablation in 3 swine.

117 Compared with sequential focal radiofrequency ablation in a linear pattern, an irrigate

118 Dominant frequency decreased after radiofrequency ablation in both cases and VF terminated

119 ndomized controlled trial of surveillance vs radiofrequency ablation in Europe.

120 achycardia ablation in 2 patients (irrigated radiofrequency ablation in one and cryoablation in the o

121 2 first-degree family members) who underwent radiofrequency ablation in our institution and in anothe

122 l and epicardial substrate-based mapping and radiofrequency ablation in patients with scar-related ve

123 ther cryoballoon ablation was noninferior to radiofrequency ablation in symptomatic patients with dru

124 Our hypothesis is that radiofrequency ablation in the early postinfarct period

125 lation (PFA) provides safety advantages over radiofrequency ablation in treating atrial fibrillation.

126 Radiofrequency ablation induced platelet activation in b

127 Radiofrequency ablation inside pulmonary vein (PV) ostia

128 Radiofrequency ablation inside PV ostia causes considera

129 nd collateral injury compared with irrigated radiofrequency ablation (IRF).

130 Radiofrequency ablation is a commonly used clinical proc

131 Radiofrequency ablation is an accepted therapy in patien

132 Duty-cycled radiofrequency ablation is associated with significantly

133 wever, efficacious RDN is only achieved when radiofrequency ablation is delivered to the nonstented R

134 Standard radiofrequency ablation is effective in eliminating atri

135 Radiofrequency ablation is feasible and safe for patient

136 Radiofrequency ablation is feasible without altering ext

137 Image-guided radiofrequency ablation is now the standard treatment fo

138 Radiofrequency ablation is routinely used to treat cardi

139 Conclusion Bone tumor radiofrequency ablation is safe, with a low rate of majo

140 Contact force-guided radiofrequency ablation is the dominant technique and pu

141 Radiofrequency ablation is the most common method, and c

142 the combination of endoscopic resection and radiofrequency ablation is the most effective therapy, a

143 The effect of percutaneous left atrial radiofrequency ablation (LARFA) of AF on the risk of TEs

144 n]), and thermal ablative therapies (such as radiofrequency ablation, laser induced thermotherapy, mi

145 In animal studies of radiofrequency ablation, lesion sizes plateau as the max

146 In 7 of 9 animals, circumferential radiofrequency ablation lesions were applied periostiall

147 es and differences between imaging cryo- and radiofrequency ablation lesions when using ultraviolet a

148 ing (MRI) has been used to acutely visualize radiofrequency ablation lesions, but its accuracy in pre

149 MRI are used to visualize and evaluate acute radiofrequency ablation lesions.

150 from the surrounding edematous rims in acute radiofrequency ablation lesions.

151 the His bundle was isolated using sequential radiofrequency ablation lesions.

152 inical trial comparing multielectrode-phased radiofrequency ablation (MEA) to standard focal irrigate

153 The specific ablative modalities of radiofrequency ablation, microwave ablation, laser ablat

154 e control group of patients with AF awaiting radiofrequency ablation (n = 30).

155 myocardial infarction who were referred for radiofrequency ablation of AF were studied.

156 124 tested sites for 30 patients undergoing radiofrequency ablation of atrial and ventricular re-ent

157 to perform left and right atrial mapping and radiofrequency ablation of atrial fibrillation (AF) and

158 ate the feasibility, safety, and outcomes of radiofrequency ablation of atrial fibrillation (AF) in p

159 Radiofrequency ablation of atrial fibrillation has been

160 any effect on platelet activation induced by radiofrequency ablation of atrial fibrillation.

161 odest short-term efficacy is achievable with radiofrequency ablation of chronic AF guided by complex

162 Background Radiofrequency ablation of intramural ventricular substr

163 Radiofrequency ablation of multiple or unmappable ventri

164 Contact force-guided radiofrequency ablation of persistent atrial fibrillatio

165 Radiofrequency ablation of previously stented RA demonst

166 Radiofrequency ablation of PVC foci improves LV function

167 78% men, QRS duration of 155 +/- 18 ms) had radiofrequency ablation of PVC from 76 foci.

168 dy was to correlate response to endovascular radiofrequency ablation of renal arteries with nerve and

169 The long-term efficacy of radiofrequency ablation of renal autonomic nerves has be

170 tients, including 6 who underwent successful radiofrequency ablation of the arrhythmic focus without

171 Percutaneous radiofrequency ablation of the CB abolished the adenosin

172 rteries only, whereas a combined approach of radiofrequency ablation of the main arteries, accessorie

173 y main renal artery ablation, 39 to combined radiofrequency ablation of the main artery and branches,

174 asound-based RDN was found to be superior to radiofrequency ablation of the main renal arteries only,

175 ardioneuroablation, the vagal denervation by radiofrequency ablation of the neuromyocardial interface

176 After radiofrequency ablation of the nonstented RA, sympatheti

177 ased on carotid baroreceptor stimulation and radiofrequency ablation of the renal nerves.

178 After radiofrequency ablation of the RPA GP, continuous progra

179 Catheter radiofrequency ablation of ventricular arrhythmias (VAs)

180 tation, and local ablative therapies such as radiofrequency ablation offer potential cure for tumors

181 ntional catheter ablation, intramural needle radiofrequency ablation offers significant arrhythmia co

182 Radiofrequency ablation on the eighth day after infarcti

183 al fibrillation, for which she had undergone radiofrequency ablation on two occasions.

184 and either temperature-controlled irrigated radiofrequency ablation or PFA anteriorly (RF/PF or PF/P

185 nitinol tip is able to deliver either focal radiofrequency ablation or PFA lesions, each in 2 to 5 s

186 We compared characteristics and VT radiofrequency ablation outcomes of those with and witho

187 arterial chemoembolization, liver resection, radiofrequency ablation, percutaneous ethanol injection,

188 our study was to determine if cooling during radiofrequency ablation preserved the RA while allowing

189 gnetic resonance relaxometry showed that the radiofrequency ablation procedure changes the intrinsic

190 alization of tissue necrosis during cryo- or radiofrequency ablation procedures.

191 ult dogs (n=27) underwent left bundle-branch radiofrequency ablation, prolonging the QRS by 100%.

192 With radiofrequency ablation, PV ostial diameter decreased 23

193 ollow up for computed tomography (CT)-guided radiofrequency ablation [RA] therapy for osteoid osteoma

194 recurrence of atrial fibrillation (AF) after radiofrequency ablation remains significant.

195 tes, which may be definitively eliminated by radiofrequency ablation, remains unknown.

196 confirmed diagnosis of low-grade dysplasia, radiofrequency ablation resulted in a reduced risk of ne

197 Radiofrequency ablation resulted in hyperenhancement of

198 AES elimination by radiofrequency ablation results in ECG normalization and

199 Radiofrequency ablation results in heterogeneous injury

200 ld's A cirrhosis and stage II HCC treated by radiofrequency ablation (RFA) +/- transarterial chemoemb

201 New developments include studies combining radiofrequency ablation (RFA) and endoscopic mucosal res

202 RECENT FINDINGS: Radiofrequency ablation (RFA) and endoscopic mucosal res

203 Endovenous ablation of varicose veins using radiofrequency ablation (RFA) and endovenous laser thera

204 ssment in malignant lung tumors treated with radiofrequency ablation (RFA) and for the detection and

205 ressed genes in the periablational rim after radiofrequency ablation (RFA) and their role in driving

206 Resection and radiofrequency ablation (RFA) are treatment options for

207 nsplantation (LT), liver resection (LR), and radiofrequency ablation (RFA) as initial therapy for ear

208 Radiofrequency ablation (RFA) can eradicate dysplasia an

209 ety of VGLB ablation with standard irrigated radiofrequency ablation (RFA) during catheter ablation o

210 en stereotactic body radiotherapy (SBRT) and radiofrequency ablation (RFA) for HCC.

211 patients treated with no-touch multibipolar radiofrequency ablation (RFA) for hepatocellular carcino

212 otactic body radiation therapy (SBRT) versus radiofrequency ablation (RFA) for patients with inoperab

213 he current literature addressing the role of radiofrequency ablation (RFA) for the management of rena

214 Radiofrequency ablation (RFA) from the epicardial space

215 Radiofrequency ablation (RFA) has been shown to be an ef

216 pro-oncogenic effects compared with hepatic radiofrequency ablation (RFA) in an animal model.

217 ce on the efficacy, durability and safety of radiofrequency ablation (RFA) in Barrett's esophagus are

218 ivaroxaban administration during left atrial radiofrequency ablation (RFA) in comparison with uninter

219 of patients with BE and dysplasia treated by radiofrequency ablation (RFA) in the randomized controll

220 To describe the use of endobiliary radiofrequency ablation (RFA) in the treatment of malign

221 Percutaneous radiofrequency ablation (RFA) is a minimally invasive te

222 Radiofrequency ablation (RFA) is a potentially curative

223 BACKGROUND & AIMS: Radiofrequency ablation (RFA) is a safe alternative to e

224 Radiofrequency ablation (RFA) is an established treatmen

225 Contact force (CF) during radiofrequency ablation (RFA) is an important determinan

226 Radiofrequency ablation (RFA) is commonly used to treat

227 Background Percutaneous radiofrequency ablation (RFA) is effective in the manage

228 safety and efficacy of one- vs. two-session radiofrequency ablation (RFA) of parathyroid hyperplasia

229 ormed using a laparoscopic approach, whereas radiofrequency ablation (RFA) of the SRM is more commonl

230 Radiofrequency ablation (RFA) of ventricular tachycardia

231 of this study was to examine the effects of radiofrequency ablation (RFA) on tumor growth and growth

232 BACKGROUND & AIMS: Radiofrequency ablation (RFA) reduces the risk of esopha

233 gly receive endoscopic mucosal resection and radiofrequency ablation (RFA) therapy.

234 g on the atrial thrombogenic milieu by using radiofrequency ablation (RFA) to create a quantifiable p

235 three-dimensional (3D)-navigated multiprobe radiofrequency ablation (RFA) with intraprocedural image

236 combination therapy of a lung tumor by using radiofrequency ablation (RFA) with local injection of an

237 the risk of coronary artery (CA) injury with radiofrequency ablation (RFA) within the coronary venous

238 st-line curative treatment: liver resection, radiofrequency ablation (RFA), and liver transplantation

239 ive ultrasound and biopsy only, laparoscopic radiofrequency ablation (RFA), and minimally invasive re

240 Most recent data describe radiofrequency ablation (RFA), but other data pertain to

241 Radiofrequency ablation (RFA), with or without endoscopi

242 ergy that may provide safety advantages over radiofrequency ablation (RFA).

243 gus (BE) often requires multiple sessions of radiofrequency ablation (RFA).

244 lesions that were subsequently treated with radiofrequency ablation (RFA).

245 pared the effects of newer biphasic PFA with radiofrequency ablation (RFA).

246 rett's esophagus are frequently treated with radiofrequency ablation (RFA).

247 rring is visualized at high resolution after radiofrequency ablation (RFA).

248 y-stage hepatocellular carcinoma (HCC) after radiofrequency ablation (RFA).

249 ic tumors not suitable for thermal ablation (radiofrequency ablation [RFA] or microwave ablation).

250 patients treated with surgery (resection +/- radiofrequency ablation [RFA]) for colorectal liver meta

251 gus-related LGD undergoing ablative therapy, radiofrequency ablation should be used.

252 Endoscopic eradication therapy with radiofrequency ablation significantly reduces the freque

253 Remote heating of metal located near a radiofrequency ablation source has been previously demon

254 linical outcomes of multi-probe stereotactic radiofrequency ablation (SRFA) for very large (>=8 cm) p

255 d quality of life (HRQoL) after stereotactic radiofrequency ablation (SRFA) of liver tumors and ident

256 y ablation (MEA) to standard focal irrigated radiofrequency ablation (STA) using 3-dimensional naviga

257 cal model, a novel, high-current low-density radiofrequency ablation strategy created contiguous and

258 Renal denervation (RDN) with radiofrequency ablation substantially reduces blood pres

259 probe-ablative therapy with cryoablation and radiofrequency ablation suggest satisfactory outcomes by

260 Catheter-based radiofrequency ablation technology to disrupt both effer

261 ble spectrum, which was in stark contrast to radiofrequency ablation that markedly increased the inte

262 Radiofrequency ablation that selectively targeted the si

263 ed lung denervation (TLD) is a bronchoscopic radiofrequency ablation therapy for chronic obstructive

264 Radiofrequency ablation therapy has been reintroduced an

265 capture group (P=0.002 and P<0.001), whereas radiofrequency ablation time was comparable (P=0.192).

266 Radiofrequency ablation to achieve PVAI is a promising a

267 sed cardiac magnetic resonance imaging after radiofrequency ablation to investigate the hypothesis th

268 is agent to take advantage of the ability of radiofrequency ablation to, at least temporarily, damage

269 and pharmacological strategies (and possibly radiofrequency ablation) to control atrial fibrillation

270 other treatments, for example, radiation or radiofrequency ablation, to trigger drug release from th

271 lity therapy consisted of hepatic resection, radiofrequency ablation, transarterial chemoembolization

272 Patients with paroxysmal AF who received radiofrequency ablation treatment were randomized to a 3

273 atients with dysplastic Barrett's esophagus, radiofrequency ablation was associated with a high rate

274 ponse of PVs to circular electroporation and radiofrequency ablation was compared.

275 Radiofrequency ablation was conducted in 17 patients and

276 Nerve injury after radiofrequency ablation was greatest at 7 days, with max

277 Subsequently, radiofrequency ablation was investigated within the sten

278 +/-8.2 seconds; for the remainder, irrigated radiofrequency ablation was necessary.

279 Focal nerve regeneration at the sites of radiofrequency ablation was observed in 17% of renal art

280 Radiofrequency ablation was performed at isthmus sites a

281 Radiofrequency ablation was performed during VF in 2 pat

282 Radiofrequency ablation was performed in 17 lesions; mic

283 on was performed in 27 (61%), and epicardial radiofrequency ablation was performed in 4 (9%) patients

284 Radiofrequency ablation was performed in a consecutive g

285 s (mean age, 57+/-11 years) with chronic AF, radiofrequency ablation was performed to target complex

286 Inside the other PV, circular radiofrequency ablation was performed using 30 W radiofr

287 In contrast, when radiofrequency ablation was performed within the stented

288 Radiofrequency ablation was successful in 9 patients on

289 Radiofrequency ablation was used to create epicardial co

290 h local treatment (surgery, radiotherapy, or radiofrequency ablation), was performed.

291 patients with atrial fibrillation undergoing radiofrequency ablation were included.

292 tive AF patients (53% paroxysmal) undergoing radiofrequency ablation were recruited.

293 re combined with right or left bundle branch radiofrequency ablation were studied.

294 Forty-eight radiofrequency ablations were performed.

295 In comparing radiofrequency ablation with antiarrhythmic drug therapy

296 Radiofrequency ablation with contact force sensing was t

297 ndomized, controlled trial and randomized to radiofrequency ablation with either a novel CF-sensing c

298 ial, cryoballoon ablation was noninferior to radiofrequency ablation with respect to efficacy for the

299 nd 3 repeat procedures (using cryoballoon or radiofrequency ablation with similar success rates) were

300 of FeO nanoparticles allowed for facilitated radiofrequency ablation without direct infiltration into